• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 76 of 100
Anacor Stock Soars More Than 50% on Pfizer Takeover Deal
FinanceAnacor Stock Soars More Than 50% on Pfizer Takeover Deal
By ReutersMay 16, 2016
FRANCE-ECONOMY-PHARMACEUTICALS-SANOFI
HealthSanofi Is Moving to Replace Medivation’s Entire Board in Takeover Bid
By Sy MukherjeeMay 13, 2016
Big Pharma Innovation in Small Places
HealthBig Pharma Innovation in Small Places
By Jennifer AlseverMay 13, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceHospitals Say Valeant Isn’t Meeting Its Discount Promise
By Lucinda ShenMay 12, 2016
155292424
HealthAnother Major Insurer Is Tying Drug Prices to Health Outcomes
By Sy MukherjeeMay 11, 2016
Squawk Box - Season 20
FinanceBill Ackman Just Unloaded $800 Million in Shares of This Pharma Firm
By ReutersMay 11, 2016
This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
FinanceThis Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
By Laura LorenzettiMay 10, 2016
Fortune Global Forum 2015
LeadershipMeet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals
By Bill GeorgeMay 10, 2016
New England Towns Struggle With Opioid And Heroin Epidemic
HealthOxyContin’s 12-Hour Dosing Claim Attacked In Massive Investigation
By Sy MukherjeeMay 6, 2016
Fortune Brainstorm Tech 2015
FinanceDiabetes ‘Unicorn’ Intarcia Hits Major Milestone
By Dan PrimackMay 6, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck CEO: We’re on the Hunt for Deals in 2016
By Sy MukherjeeMay 6, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
HealthValeant Says it Has a New Way to Ensure it Doesn’t Price Gouge So Much
By ReutersMay 6, 2016
Sanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
HealthSanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
By ReutersMay 6, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
HealthNow It’s Pfizer That Wants to Buy Cancer Drug Maker Medivation
By ReutersMay 4, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
FinanceThese Biopharma Companies Are the World’s Top Shareholder Value Creators
By Sy MukherjeeMay 3, 2016
1...
  • 74
  • 75
  • 76
  • 77
  • 78
...100
Most Popular
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Retail
Amazon's record Prime Day masks a darker truth: Americans are spending more and getting lessplaceholder alt text
By Nick LichtenbergJune 24, 2026
Asia
Ray Dalio just finished a 10-day trip to China. He says global leaders know America ‘doesn’t have what it takes to fight to maintain its empire’placeholder alt text
By Nick LichtenbergJune 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.